Clinical Evaluation of Intravitreal Injection of Ganciclovir in Refractory Corneal Endotheliitis

Ocular Immunology and Inflammation
Ting YuJing Hong

Abstract

Purpose: To evaluate the efficacy and safety of intravitreal ganciclovir (GCV) injection in refractory endotheliitis.Methods: Retrospectively recruited 25 eyes with endotheliitis, proved by clinical manifestations, positive PCR for viral DNA and responded poor to topical and systemic antiviral medications. All patients received additional continued intravitreal GCV injections.Results: Cytomegalovirus (CMV), varicella zoster virus (VZV), and herpes simplex virus (HSV) DNA were detected in 64.0%, 28.0%, and 8.0% of the eyes, respectively. Within 2 weeks after the last injection, 16/25 eyes recovered corneal clarity; active keratic precipitates (KPs) were eliminated in 21/25 eyes; intraocular pressure (IOP) was controlled in 12/15 eyes with elevated IOP on study entry. Best-corrected visual acuity increased at the last follow-up (p = 0.016). Clinical recurrence occurred in three patients. No complications were detected.Conclusions: CMV endotheliitis was the main type of refractory endotheliitis. Despite its invasive nature, intravitreal GCV injection appears to be an effective method for refractory endotheliitis.

References

Oct 15, 1991·American Journal of Ophthalmology·Y OhashiR Manabe
Feb 1, 1986·The British Journal of Ophthalmology·J SchulmanP de Miranda
Jul 1, 1983·Proceedings of the National Academy of Sciences of the United States of America·A K FieldR L Tolman
Jun 1, 1982·American Journal of Ophthalmology·A A Khodadoust, A Attarzadeh
Sep 5, 1996·The New England Journal of Medicine·C S Crumpacker
Mar 20, 2004·Journal of Cataract and Refractive Surgery·Jack T Holladay
Feb 24, 2006·American Journal of Ophthalmology·Noriko KoizumiShigeru Kinoshita
Mar 2, 2006·Expert Opinion on Drug Delivery·Deepta Ghate, Henry F Edelhauser
Feb 8, 2008·American Journal of Ophthalmology·Soon-Phaik CheeBan Hock Tan
Jun 28, 2008·Seminars in Ophthalmology·Takashi Suzuki, Yuichi Ohashi
Feb 24, 2009·Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics·Kumar G JanoriaAshim K Mitra
Sep 29, 2009·Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Für Klinische Und Experimentelle Ophthalmologie·Yih-Shiou HwangChing-Hsi Hsiao
Jun 26, 2010·The British Journal of Ophthalmology·S-P Chee, A Jap
Sep 22, 2010·Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Für Klinische Und Experimentelle Ophthalmologie·Yih-Shiou HwangChing-Hsi Hsiao
Nov 10, 2011·Arquivos brasileiros de oftalmologia·Fabio Felipe dos SantosRubens Belfort Junior
Dec 17, 2011·Eye·A Carmichael
Apr 2, 2013·Korean Journal of Ophthalmology : KJO·Won Seok ChoiYoung Joo Shin
May 31, 2014·Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics·Bin WangXiao-Xin Li
May 5, 2016·The British Journal of Ophthalmology·Noriko KoizumiShigeru Kinoshita

❮ Previous
Next ❯

Citations

Sep 16, 2020·Ocular Immunology and Inflammation·Abdulaziz Ismail Al Somali, Wael Otaif
Jan 15, 2021·Eye and Vision·Angela H Y WongKelvin H Wan

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.